Depression, Anxiety May Be Signs That COVID-19 Is Attacking Brain
Depression and anxiety exhibited in COVID-19 patients may be a sign that the virus impacts the central nervous system.
General Psychiatry
Efficacy of Bundled HIV, HCV Testing for People With Substance Abuse Disorders Examined
By providing bundled HIV and HCV testing, substance use disorder treatment programs may create increased awareness of infection status among people with substance abuse disorders.
COVID-19 Pandemic Exacerbates Mental Health Issues
Just as the physical symptoms of COVID-19 vary among the population, mental health is enduring a variety of effects from the virus as well.
Psychosis Treatments
A comparative dosing and titration chart of commonly used first-generation and second-generation antipsychotics.
Psychotropic Drug Indications
A comparative list of psychotropic medications with their mood disorder indications (bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others).
ADHD Treatments
Attention Deficit Hyperactivity Disorder (ADHD) treatment medications comparative chart.
Mood Disorders With HIV Increase Risk for Noncommunicable Disease
Focused prevention and treatment of noncommunicable diseases may reduce the burden of multimorbidity in people living with HIV who have mood disorders and multimorbidity.
Buprenorphine Treatment Linked to Decreased HIV RNA Viral Loads
Buprenorphine treatments for opioid use disorder among people living with HIV demonstrated beneficial effects in terms of viral load.
Viral Hepatitis and Psychiatric Disorders in Adults, Youths
Hepatitis viruses are associated with a higher risk for psychiatric conditions in both adults and children.
-
Loading...
-
Loading...
